Labcorp Holdings annual net profit margin
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Net Profit Margin Growth & History (LH)
Labcorp Holdings's net profit margin was 6.28% for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 6.28% | +0.55 pp |
| 2024 | 2024-12-31 | 5.73% | +2.30 pp |
| 2023 | 2023-12-31 | 3.44% | −7.34 pp |
| 2022 | 2022-12-31 | 10.78% | −7.32 pp |
| 2021 | 2021-12-31 | 18.10% | +6.97 pp |
| 2020 | 2020-12-31 | 11.13% | +4.00 pp |
| 2019 | 2019-12-31 | 7.13% | −0.67 pp |
| 2018 | 2018-12-31 | 7.80% | −4.11 pp |
| 2017 | 2017-12-31 | 11.90% | +4.45 pp |
| 2016 | 2016-12-31 | 7.45% | +2.41 pp |
| 2015 | 2015-12-31 | 5.04% | −3.46 pp |
| 2014 | 2014-12-31 | 8.50% | −1.38 pp |
| 2013 | 2013-12-31 | 9.88% | −0.40 pp |
| 2012 | 2012-12-31 | 10.28% | +0.90 pp |
| 2011 | 2011-12-31 | 9.38% | −1.78 pp |
| 2010 | 2010-12-31 | 11.16% | −0.42 pp |
| 2009 | 2009-12-31 | 11.57% | +1.26 pp |
| 2008 | 2008-12-31 | 10.31% | −1.41 pp |
| 2007 | 2007-12-31 | 11.72% | — |
Labcorp Holdings quarterly net profit margin
Q2.08
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 8.01% | +1.26 pp |
| Q1 2026 | 2026-03-31 | 7.85% | +1.49 pp |
| Q4 2025 | 2025-12-31 | 4.68% | +0.38 pp |
| Q3 2025 | 2025-09-30 | 7.33% | +2.17 pp |
| Q2 2025 | 2025-06-30 | 6.74% | +0.37 pp |
| Q1 2025 | 2025-03-31 | 6.36% | −0.82 pp |
| Q4 2024 | 2024-12-31 | 4.31% | +9.82 pp |
| Q3 2024 | 2024-09-30 | 5.16% | −0.84 pp |
| Q2 2024 | 2024-06-30 | 6.37% | +0.15 pp |
| Q1 2024 | 2024-03-31 | 7.18% | +0.17 pp |
| Q4 2023 | 2023-12-31 | −5.51% | −9.01 pp |
| Q3 2023 | 2023-09-30 | 6.00% | −6.31 pp |
| Q2 2023 | 2023-06-30 | 6.23% | −6.04 pp |
| Q1 2023 | 2023-03-31 | 7.01% | −5.60 pp |
| Q4 2022 | 2022-12-31 | 3.50% | −48.12 pp |
| Q3 2022 | 2022-09-30 | 12.31% | −2.15 pp |
| Q2 2022 | 2022-06-30 | 12.27% | +0.10 pp |
| Q1 2022 | 2022-03-31 | 12.61% | −5.89 pp |
| Q4 2021 | 2021-12-31 | 51.62% | +30.72 pp |
| Q3 2021 | 2021-09-30 | 14.46% | −3.60 pp |
| Q2 2021 | 2021-06-30 | 12.17% | +3.81 pp |
| Q1 2021 | 2021-03-31 | 18.49% | +29.73 pp |
| Q4 2020 | 2020-12-31 | 20.90% | +13.21 pp |
| Q3 2020 | 2020-09-30 | 18.05% | +28.89 pp |
| Q2 2020 | 2020-06-30 | 8.36% | +1.76 pp |
| Q1 2020 | 2020-03-31 | −11.23% | −17.88 pp |
| Q4 2019 | 2019-12-31 | 7.69% | +2.02 pp |
| Q3 2019 | 2019-09-30 | −10.83% | −22.09 pp |
| Q2 2019 | 2019-06-30 | 6.61% | −1.55 pp |
| Q1 2019 | 2019-03-31 | 6.65% | +0.57 pp |
| Q4 2018 | 2018-12-31 | 5.66% | −19.39 pp |
| Q3 2018 | 2018-09-30 | 11.26% | +4.72 pp |
| Q2 2018 | 2018-06-30 | 8.16% | +0.85 pp |
| Q1 2018 | 2018-03-31 | 6.08% | −1.50 pp |
| Q4 2017 | 2017-12-31 | 25.06% | +17.33 pp |
| Q3 2017 | 2017-09-30 | 6.54% | −0.89 pp |
| Q2 2017 | 2017-06-30 | 7.31% | −1.09 pp |
| Q1 2017 | 2017-03-31 | 7.58% | +5.88 pp |
| Q4 2016 | 2016-12-31 | 7.72% | +2.82 pp |
| Q3 2016 | 2016-09-30 | 7.43% | +0.76 pp |
| Q2 2016 | 2016-06-30 | 8.40% | +0.91 pp |
| Q1 2016 | 2016-03-31 | 1.70% | +1.53 pp |
| Q4 2015 | 2015-12-31 | 4.90% | −3.01 pp |
| Q3 2015 | 2015-09-30 | 6.68% | −2.17 pp |
| Q2 2015 | 2015-06-30 | 7.49% | −1.83 pp |
| Q1 2015 | 2015-03-31 | 0.17% | −8.34 pp |
| Q4 2014 | 2014-12-31 | 7.91% | −0.89 pp |
| Q3 2014 | 2014-09-30 | 8.84% | −1.30 pp |
| Q2 2014 | 2014-06-30 | 9.32% | −1.03 pp |
| Q1 2014 | 2014-03-31 | 8.50% | −1.71 pp |
| Q4 2013 | 2013-12-31 | 8.80% | +0.24 pp |
| Q3 2013 | 2013-09-30 | 10.14% | −0.28 pp |
| Q2 2013 | 2013-06-30 | 10.35% | −0.42 pp |
| Q1 2013 | 2013-03-31 | 10.22% | −1.14 pp |
| Q4 2012 | 2012-12-31 | 8.55% | −1.36 pp |
| Q3 2012 | 2012-09-30 | 10.43% | +0.86 pp |
| Q2 2012 | 2012-06-30 | 10.77% | +2.01 pp |
| Q1 2012 | 2012-03-31 | 11.35% | +2.07 pp |
| Q4 2011 | 2011-12-31 | 9.91% | −0.26 pp |
| Q3 2011 | 2011-09-30 | 9.56% | −1.41 pp |
| Q2 2011 | 2011-06-30 | 8.76% | −3.65 pp |
| Q1 2011 | 2011-03-31 | 9.29% | −1.83 pp |
| Q4 2010 | 2010-12-31 | 10.17% | −2.07 pp |
| Q3 2010 | 2010-09-30 | 10.97% | −0.12 pp |
| Q2 2010 | 2010-06-30 | 12.41% | +0.94 pp |
| Q1 2010 | 2010-03-31 | 11.12% | −0.37 pp |
| Q4 2009 | 2009-12-31 | 12.25% | — |
| Q3 2009 | 2009-09-30 | 11.09% | +1.23 pp |
| Q2 2009 | 2009-06-30 | 11.47% | +2.40 pp |
| Q1 2009 | 2009-03-31 | 11.49% | — |
| Q3 2008 | 2008-09-30 | 9.86% | — |
| Q2 2008 | 2008-06-30 | 9.08% | — |
Labcorp Holdings net profit margin trends
Over the last five fiscal years, Labcorp Holdings's net profit margin decreased from 11.13% to 6.28%, a change of −4.85 percentage points. The latest reported quarter, Q2 2026, shows 8.01%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...